Nanosuspensions as delivery system for gambogenic acid: characterization and in vitro/in vivo evaluation

References

• Aditya NP, Yang H, Kim S, et al. (2015). Fabrication of amorphous curcumin nanosuspensions using-lactoglobulin to enhance solubility, stability, and bioavailability. Colloids Surf B Biointerfaces 127:114–21
   PubMed Web of Science ®Google Scholar
• Asano J, Chiba K, Tada M, et al. (1996). Cytotoxic xanthones from Garcinia hanburyi. Phytochemistry 41:815–20
   PubMed Web of Science ®Google Scholar
• Bajaj A, Rao MR, Pardeshi A, et al. (2012). Nanocrystallization by evaporative antisolvent technique for solubility and bioavailability enhancement of telmisartan. AAPS PharmSciTech 13:1331–40
   PubMed Web of Science ®Google Scholar
• Cerdeira AM, Werner IA, Mazzotti M, et al. (2012). Simultaneous quantification of polymeric and surface active stabilizers of nanosuspensions by using near-infrared spectroscopy. Drug Dev Ind Pharm 38:1360–70
   PubMed Web of Science ®Google Scholar
• Chin WWL, Parmentier J, Widzinski M, et al. (2014). A brief literature and patent review of nanosuspensions to a final drug product. J Pharm Sci 103:2980–99
   PubMed Web of Science ®Google Scholar
• Fan Y, Peng A, He S, et al. (2013). Isogambogenic acid inhibits tumour angiogenesis by suppressing Rho GTPases and vascular endothelial growth factor receptor 2 signalling pathway. J Chemother 25:298–308
   PubMed Web of Science ®Google Scholar
• Gao L, Zhang D, Chen M. (2008). Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system. J Nanopart Res 10:845–62
   Web of Science ®Google Scholar
• He W, Lu Y, Qi J, et al. (2013). Food proteins as novel nanosuspension stabilizers for poorly water-soluble drugs. Int J Pharm 441:269–78
   PubMed Web of Science ®Google Scholar
• Hua X, Liang C, Dong L, et al. (2015). Simultaneous determination and pharmacokinetic study of gambogic acid and gambogenic acid in rat plasma after oral administration of Garcinia hanburyi extracts by LC-MS/MS. Biomed Chromatogr 29:545–51
   PubMed Web of Science ®Google Scholar
• Huang X, Chen YJ, Peng DY, et al. (2013). Solid lipid nanoparticles as delivery systems for gambogenic acid. Colloids Surf B Biointerfaces 102:391–7
   PubMed Web of Science ®Google Scholar
• Hong C, Dang Y, Lin G, et al. (2014). Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation. Int J Pharm 477:251–60
   PubMed Web of Science ®Google Scholar
• Hu X, Chen X, Zhang L, et al. (2014). A combined bottom–up/top–down approach to prepare a sterile injectable nanosuspension. Int J Pharm 472:130–9
   PubMed Web of Science ®Google Scholar
• Jacobs C, Kayser O, Müller RH. (2000). Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide. Int J Pharm 196:161–4
   PubMed Web of Science ®Google Scholar
• Kumar S, Xu X, Gokhale R, et al. (2014). Formulation parameters of crystalline nanosuspensions on spray drying processing: a DOE approach. Int J Pharm 464:34–45
   PubMed Web of Science ®Google Scholar
• Kuo YC, Shih KH, Yang JT. (2010). Capillary electrophoresis of bone marrow stromal cells with uptake of heparin-functionalized poly(lactide-co-glycolide) nanoparticles during differentiation towards neurons. Electrophoresis 31:315–23
   PubMed Web of Science ®Google Scholar
• Li Q, Cheng H, Zhu G, et al. (2010). Gambogenic acid inhibits proliferation of A549 cells through apoptosis inducing and cell cycle arresting. Biol Pharm Bull 33:415–20
   PubMed Web of Science ®Google Scholar
• Li Y, Wu Z, He W, et al. (2015). Globular protein-coated paclitaxel nanosuspensions: interaction mechanism, direct cytosolic delivery and significant improvement in pharmacokinetics. Mol Pharm 12:1485–500
   PubMed Web of Science ®Google Scholar
• Lin T, Fang Q, Peng D, et al. (2013). PEGylated non-ionic surfactant vesicles as drug delivery systems for gambogenic acid. Drug Deliv 20:277–84
   PubMed Web of Science ®Google Scholar
• Liu G, Zhang D, Jiao Y, et al. (2013). In vitro and in vivo evaluation of riccardin D nanosuspensions with different particle size. Colloids Surf B Biointerfaces 102:620–6
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang D, Duan C, et al. (2012). Studies on pharmacokinetics and tissue distribution of bifendate nanosuspensions for intravenous delivery. J Microencapsul 29:194–203
   PubMed Web of Science ®Google Scholar
• Matteucci M, Hotze M, Johnston K, et al. (2006). Drug nanoparticles by antisolvent precipitation: mixing energy versus surfactant stabilization. Langmuir 22:8951–9
   PubMed Web of Science ®Google Scholar
• Singh G, Pai RS. (2014). Optimized PLGA nanoparticle platform for orally dosed trans-resveratrol with enhanced bioavailability potential. Expert Opin Drug Deliv 11:647–59
   PubMed Web of Science ®Google Scholar
• Tian X, Li H, Zhang D, et al. (2013). Nanosuspension for parenteral delivery of a p-terphenyl derivative: preparation, characteristics and pharmacokinetic studies. Colloids Surf B Biointerfaces 108:29–33
   PubMed Web of Science ®Google Scholar
• Tran TT, Tran PH, Nguyen MN, et al. (2014). Amorphous isradipine nanosuspension by the sonoprecipitation method. Int J Pharm 474:146–50
   PubMed Web of Science ®Google Scholar
• Van Eerdenbrugh B, Van den Mooter G, Augustijns P. (2008). Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. Int J Pharm 364:64–75
   PubMed Web of Science ®Google Scholar
• Verma S, Gokhale R, Burgess DJ. (2009). A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions. Int J Pharm 380:216–22
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang L, Wang Q, et al. (2013). Stability issue of nanosuspensions in drug delivery. J Control Release 172:1126–41
   PubMed Web of Science ®Google Scholar
• Wang M, Chen D, Cheng H, et al. (2014). Gambogenic acid kills lung cancer cells through aberrant autophagy. PLoS One 9:e83604
   PubMed Web of Science ®Google Scholar
• Wen H, Dong C, Dong H, et al. (2012). Engineered redox-responsive PEG detachment mechanism in PEGylated nano-graphene oxide for intracellular drug delivery. Small 8:760–9
   PubMed Web of Science ®Google Scholar
• Xia D, Quan P, Piao H, et al. (2010). Preparation of stable nitrendipine nanosuspensions using the precipitation–ultrasonication method for enhancement of dissolution and oral bioavailability. Eur J Pharm Sci 40:325–34
   PubMed Web of Science ®Google Scholar
• Zhang X, Guan J, Ni R, et al. (2014). Preparation and solidification of redispersible nanosuspensions. J Pharm Sci 103:2166–76
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang J. (2014). Preparation of budesonide nanosuspensions for pulmonary delivery: characterization, in vitro release and in vivo lung distribution studies. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. DOI: 10.3109/21691401.2014.944645
   Web of Science ®Google Scholar
• Zimmermann A, Millqvist-Fureby A, Elema, MR, et al. (2009). Adsorption of pharmaceutical excipients onto microcrystals of siramesine hydrochloride: effects on physicochemical properties. Eur J Pharm Biopharm 71:109–16
   PubMed Web of Science ®Google Scholar
• Zhou A, Li QL, Peng DY, et al. (2008). Determination of the content of gambogic acid and gambogenic acid in gamboge by HPLC. J Sep Sci 15:53–4
   Google Scholar
• Zhou J, Luo Y, Wang J, et al. (2013). Gambogenic acid induction of apoptosis in a breast cancer cell line. Asian Pac J Cancer Prev 14:7601–5
   PubMed Web of Science ®Google Scholar